Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/08/2009 | WO2009004093A1 Preparation of an esterase |
01/08/2009 | WO2009004085A2 Dsrna for treating viral infection |
01/08/2009 | WO2009004068A2 Androgen-dependent 1-f-aromatase reporter gene |
01/08/2009 | WO2009004066A2 Providing improved immunoglobulin sequences by mutating cdr and/or fr positions |
01/08/2009 | WO2009004002A1 Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli |
01/08/2009 | WO2009003977A2 Plants having enhanced yield-related traits and a method for making the same |
01/08/2009 | WO2009003676A1 Method for the generation of a non-human animal with an oncogene |
01/08/2009 | WO2009003671A2 Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
01/08/2009 | WO2009003654A2 Selecting nucleic acid samples suitable for genotyping |
01/08/2009 | WO2009003623A1 Heavy chain mutant leading to improved immunoglobulin production |
01/08/2009 | WO2009003622A1 Promoter |
01/08/2009 | WO2009003412A1 Bacillus thuringiensis stain, cry8g genes, proteins, which are all highly toxic to order coleoptera insect pests, and uses thereof |
01/08/2009 | WO2009003291A1 Therapeutics and diagnostics for group a streptococci |
01/08/2009 | WO2009003274A1 Susceptibility gene for inflammatory bowel disease |
01/08/2009 | WO2009003216A1 Modification of plant flavonoid metabolism |
01/08/2009 | WO2008144720A3 Inhibitors of igf-1r signaling for the treatment of respiratory disorders |
01/08/2009 | WO2008144700A3 Simian t-cell lymphotropic virus type 3 west african subtype d |
01/08/2009 | WO2008142693A3 Regulation of myelination by nectin-like (necl) molecules |
01/08/2009 | WO2008140582A3 Production of anti-microbial peptides |
01/08/2009 | WO2008139153A3 Expression system |
01/08/2009 | WO2008138649A3 Signaling peptides |
01/08/2009 | WO2008138619A3 New ttv sequences for diagnosis, prevention and treatment of childhood leukaemia |
01/08/2009 | WO2008135296A3 New hybrid system for brassica napus |
01/08/2009 | WO2008133971A3 Promoter inducible by reactive oxygen species and vector comprising the same |
01/08/2009 | WO2008124495A3 Ahas mutants |
01/08/2009 | WO2008120194A3 Transgenic plants containing soluble cell wall polysaccharides |
01/08/2009 | WO2008112226A3 Cre-lox based gene knockdown constructs and methods of use thereof |
01/08/2009 | WO2008109472A4 Nucleic acid compounds for inhibiting pcsk9 gene exprression and uses thereof |
01/08/2009 | WO2008109450A4 Nucleic acid compounds for inhibiting id-1 gene expression and uses thereof |
01/08/2009 | WO2008106646A3 Methods and formulations for topical gene therapy |
01/08/2009 | WO2008100552A3 Plants with altered root architecture, involving the rum1 gene, related constructs and methods |
01/08/2009 | WO2008091659A3 Methods and compositions for predicting and treating drug resistant strains of influenza virus |
01/08/2009 | WO2008084087A3 Dbait and its standalone uses thereof |
01/08/2009 | WO2008080166A3 Resistance management strategies for transgenic crops |
01/08/2009 | WO2008067591A8 Protein particles |
01/08/2009 | WO2008063340A9 Delta-8 desaturases and their use in making polyunsaturated fatty acids |
01/08/2009 | WO2008061156A3 Generation of plants with altered protein, fiber, or oil content |
01/08/2009 | WO2008052043A3 Opioid receptor agonist fusion proteins |
01/08/2009 | WO2008028098A3 A novel o-methyltransferase gene from sorghum cloning, expression, transformation and characterization |
01/08/2009 | WO2007117680A3 Methods and compositions for treating bacterial infection |
01/08/2009 | WO2006104035A9 Tripodal functional interface molecule for immobilization of biological molecule and device for detection of gene |
01/08/2009 | US20090013437 CONSTITUTIVE PHOTOMORPHOGENESIS 1 (COP1) NUCLEIC ACID SEQUENCE FROM Zea mays AND ITS USE THEREOF |
01/08/2009 | US20090013436 Transgenic plant with a plant transformation vector comprising a nucleotide sequence encoding a HIO32.3 polypeptide; a high oil content phenotype |
01/08/2009 | US20090013435 Clostervirus-resistant melon plants |
01/08/2009 | US20090013434 Recombinant DNA constructs and methods for controlling gene expression |
01/08/2009 | US20090013433 Compositions, cells, and plants that include BKI1, a negative regulator of BRI1-mediated BR signaling |
01/08/2009 | US20090013432 Plastidic phosphoglucomutase genes |
01/08/2009 | US20090013431 Stress tolerant cotton plants |
01/08/2009 | US20090013430 Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof |
01/08/2009 | US20090013429 Soybean variety d4021792 |
01/08/2009 | US20090013428 Soybean variety d4902530 |
01/08/2009 | US20090013427 Soybean variety d4367012 |
01/08/2009 | US20090013426 Soybean variety d4923560 |
01/08/2009 | US20090013425 Soybean variety d4253854 |
01/08/2009 | US20090013424 Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides |
01/08/2009 | US20090013423 Methods and compositions for expression of transgenes in plants |
01/08/2009 | US20090013422 Solanum Bulbocastanum polyubiquitin Bul427 promoter and uses thereof |
01/08/2009 | US20090013421 Genomic DNA fragments containing regulatory and coding sequences for the B2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
01/08/2009 | US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use |
01/08/2009 | US20090013419 Cattle beta-casein gene targeting vector using homologous recombination |
01/08/2009 | US20090013418 Trophectodermal Cell-Specific Gene Transfer Methods |
01/08/2009 | US20090013417 Transgenic Animals for Assessing Drug Metabolism and Toxicity in Man |
01/08/2009 | US20090013416 Pdes as modifiers of the igfr pathways and methods of use |
01/08/2009 | US20090012280 Oligonucleotide compound and method for treating nidovirus infections |
01/08/2009 | US20090012275 Means and methods for mediating protein interference |
01/08/2009 | US20090012270 Ox2 receptor homologs |
01/08/2009 | US20090012266 Anti-TNFalpha Antibodies and Methods of Use |
01/08/2009 | US20090012033 Delivery of Biologically Active Materials Using Core-Shell Tecto(Dendritic Polymers) |
01/08/2009 | US20090012032 novel human genes RNF43 whose expression is markedly elevated in colorectal cancers; genes and polypeptides encoded by the genes can be used in the diagnosis of a cell proliferative disease, and as target molecules for developing drugs against the disease |
01/08/2009 | US20090012030 RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION |
01/08/2009 | US20090012029 Cyst Nematode Resistant Transgenic Plants |
01/08/2009 | US20090012027 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
01/08/2009 | US20090012024 Stem Cell Markers |
01/08/2009 | US20090012023 Decoy-olignucleotide inhibition of cd40-expression |
01/08/2009 | US20090012022 Hybrid Interfering Rna |
01/08/2009 | US20090012020 Inhibiting formation of atherosclerotic lesions |
01/08/2009 | US20090012018 Inhibition of pancretic cancer cell growth |
01/08/2009 | US20090012017 Polypeptide Complex that Regulates Cell Cycle and Anergy |
01/08/2009 | US20090012016 Short Interfering Rna and Micro-Rna Compounds and Methods of Designing, Making, and Using the Same |
01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
01/08/2009 | US20090011995 Production of a soluble native form of recombinant protein by the signal sequence and secretional enhancer |
01/08/2009 | US20090011983 186 Human Secreted Proteins |
01/08/2009 | US20090011959 Method for preparing single-stranded DNA libraries |
01/08/2009 | US20090011957 Ligational encoding using building block oligonucleotides |
01/08/2009 | US20090011943 High throughput genome sequencing on DNA arrays |
01/08/2009 | US20090011936 Cytochrome P450 genes conferring herbicide resistance |
01/08/2009 | US20090011510 Device and method for biolistic transformation of cells |
01/08/2009 | US20090011509 Integrase fusion proteins and their use with integrating gene therapy |
01/08/2009 | US20090011508 Method for the production of a strain having a deleted region in chromosome |
01/08/2009 | US20090011501 Novel death domain proteins |
01/08/2009 | US20090011500 G+c rich binding protein |
01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
01/08/2009 | US20090011497 Peptides and related compounds having thrombopoietic activity |
01/08/2009 | US20090011494 Method for controlling biological function with mechanical vibration and device therefor |
01/08/2009 | US20090011490 Immunogenic minicells and methods of use |
01/08/2009 | US20090011489 Multiply-substituted protease variants |
01/08/2009 | US20090011487 Production of UGPPase |
01/08/2009 | US20090011478 Biochemical Synthesis of 1,4-Butanediamine |
01/08/2009 | US20090011476 Gene cluster and method for the biosynthesis of terrequinone a |
01/08/2009 | US20090011471 Engineered plasmids and their use for in situ production of genes |